Clinical impact of chronic renal insufficiency on endovascular aneurysm repair

Vascular and Endovascular Surgery

Volumn 40, Issue 6, 2006, Pages 437-445

  Park, Brian ^a   Mavanur, Arun ^a   Drezner, A David ^a   Gallagher, James ^a   Menzoian, James O ^b  

^a HARTFORD HOSPITAL   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Aneurysm; Endograft; Renal

Indexed keywords

ABDOMINAL AORTA ANEURYSM; ACUTE KIDNEY FAILURE; AGED; ANEURYSM SURGERY; ARTICLE; CHRONIC KIDNEY FAILURE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DISEASE SEVERITY; ENDOLEAK; ENDOVASCULAR SURGERY; FEMALE; HEART INFARCTION; HEMODIALYSIS; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PERIOPERATIVE PERIOD; PREOPERATIVE PERIOD; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

AGED; ANGIOPLASTY; AORTIC ANEURYSM, ABDOMINAL; BLOOD VESSEL PROSTHESIS IMPLANTATION; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HUMANS; INCIDENCE; KIDNEY FAILURE, ACUTE; LENGTH OF STAY; MALE; MYOCARDIAL INFARCTION; PATIENT SELECTION; PROSTHESIS FAILURE; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STENTS; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 33845642244     PISSN: 15385744     EISSN: None     Source Type: Journal    
DOI: 10.1177/1538574406294071     Document Type: Article

References (25)

1. Parodi J, Palmaz J, Barone H. Transfemoral intraluminal graft implantation for abdominal aortic aneurysms. Ann Vasc Surg. 1991 ; 5: 491-499.
2. The EVAR Trial Participants. Comparison of endovascular aneurysm repair with open repair in patients with abdominal aortic aneurysm (EVAR Trial 1), 30-day operative mortality results: randomised control trial. Lancet. 2004 ; 364: 843-848.
3. Hua H, Cambria R, Chuang S, et al. Early outcomes of endovascular versus open abdominal aortic aneurysm repair in the National Surgical Quality Improvement Program-Private Sector (NSQIP-PS). J Vasc Surg. 2005 ; 41: 382-389.
4. Harris P, Vallabhaneni R, Desgranges P, et al. Incidence and risk factors of late rupture, conversion, and death after endovascular repair of infrarenal aortic aneurysms: The EUROSTAR Experience. J Vasc Surg. 2000 ; 32: 739-749.
5. Anthony LW, Carter JW, Upchurch G, Seeger J, Huber T. Perioperative outcomes after open and endovascular repair of intact abdominal aortic aneurysms in the United States during 2001. J Vasc Surg. 2004 ; 3: 491-496.
6. Becquemin JP, Bourriez A, D'Audiffret A, et al. Midterm results of endovascular versus open repair for abdominal aortic aneurysms in patients suitable for endovascular repair. Eur J Endovasc Surg. 2000 ; 19: 656-661.
7. Carpenter J, Fairman R, Barker C, et al. Endovascular AAA repair in patients with renal insufficiency: strategies for reducing adverse renal events. Cardiovasc Surg. 2001 ; 9: 559-564.
8. Johnston, K. Multicenter prospective study of nonruptured abdominal aortic aneurysm. II: Variables in predicting morbidity and mortality. J Vasc Surg. 1989 ; 9: 437-447.
9. Hertzer NR, Mascha EJ, Karafa MT, O'Hara PJ, Krajewki LP, Beven EG. Open infrarenal abdominal aortic aneurysm repair: the Cleveland Clinic experience from 1989 to 1998. J Vasc Surg. 2002 ; 35: 1145-1154.
10. Zeebregts CJ, Geelkerken RH, Van der Palen J, Huisman AB, de Smit P, Van Det RJ. Outcome of abdominal aortic aneurysm repair in the era of endovascular treatment. Br J Surg. 2004 ; 91: 563-568.
11. Walker S, Waquar YS, Wenham P, Hopkinson B. Renal complications following endovascular repair of abdominal aortic aneurysms. J Endovasc Surg. 1998, 5: 318-322.
12. Mehta M, Veith F, Lipsitz,E, Ohki T, Russwurm G, Cayne N. Is elevated creatinine level a contraindication to endovascular aneurysm repair? J Vasc Surg. 2004 ; 39: 118-123.
13. Brewster D, Geller S, Kaufman J, et al. Initial experience with endovascular aneurysm repair: comparison of early results with outcome of conventional open repair. J Vasc Surg. 1998 ; 27: 992-1005.
14. Moore W, Matsumura J, Makaroun M, et al. Five-year interim comparison of Guidant bifurcated endograft with open repair of abdominal aortic aneurysm. J Vasc Surg. 2003 ; 38: 46-55.
15. Leschi JP, Kieffer E, Chiche L, Koskas F, Bahnini A, Benhamou AC. Combined infrarenal aorta and carotid artery reconstruction: early and late outcomes in 152 patients. Ann Vasc Surg. 2002 ; 16: 215-244.
16. Satta J, Immonen K, Reinila A, Pokela R, Juvonen T. Outcome of elective infrarenal abdominal aortic aneurysm repair-an analysis of 174 consecutive patients. Ann Chir Gynaecol. 1996 ; 85: 231-235.
17. Tassiopoulos A, Kwon S, Labropoulos N, et al. Predictors of early discharge following open abdominal aortic aneurysm repair. Ann Vasc Surg. 2004 ; 18: 218-222.
18. Prinssen M, Verhoeven E, Buth J, et al. A randomized trial comparing conventional and endovascular repair of abdominal aortic aneurysms. New Engl J Med. 2004 ; 351: 1607-1619.
19. Quinones-Baldrich W, Garner C, Caswell D, et al. Endovascular, transperitoneal, and retroperitoneal abdominal aortic aneurysm repair: results and cost. J Vasc Surg. 1999 ; 30: 59-70.
20. The UK Trial Small Aneurysm Trial Participants. Mortality results for randomized controlled trial of early elective surgery or ultrasonographic surveillance for small abdominal aortic aneurysms. Lancet. 1998 ; 352: 1649-1654.
21. Hallet J, Mills J, Earnshaw J, Jeekers J. Comprehensive Vascular and Endovascular Surgery. Boston, MA: Elsevier Publishing ; 2003: 417-418.
22. Greenburg R, Chuter T, Lawrence-Brown R, Haulon S, Nolte L. Analysis of renal function after aneurysm repair with a device using suprarenal fixation (Zenith AAA Endovascular Graft) in contrast to open surgical repair. J Vasc Surg. 2004 ; 39: 1219-1228.
23. Alsac JM, Zarins C, Heikkinen M, et al. The impact of aortic endografts on renal function. J Vasc Surg. 2005 ; 41: 926-930.
24. Merten G, Burgess P, Gray Lee, et al. Prevention of contrast-induced nephropathy with sodium bicarbonate. JAMA. 2004 ; 291: 2328-2334.
25. Tepel M, van der Giet M, Statz M, Jankowski J, Zidek W. The antioxidant acetylcysteine reduces cardiovascular events in patients with end-stage renal failure: a randomized, controlled trial. Circulation. 2005 ; 107: 992-995.